Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Clinical Nurse Specialist - A serious shortfall in numbers.
Does MOG Ig-positive AQP4-seronegative opticospinal inflammatory disease justify a diagnosis of NMO spectrum disorder?
Alemtuzumab in multiple sclerosis: an update.
Immunomodulatory activity of polysaccharides isolated from Clerodendrum splendens: Beneficial effects in experimental autoimmune encephalomyelitis.
Immunomodulatory and therapeutic effects of Hot-nature diet and co-supplemented hemp seed, evening primrose oils intervention in multiple sclerosis patients.
Clinical experience with THC:CBD oromucosal spray in patients with multiple sclerosis-related spasticity.
Neurological disorders: Differential methylation in multiple sclerosis.
B Cells Promote Induction of Experimental Autoimmune Encephalomyelitis by Facilitating Reactivation of T Cells in the Central Nervous System.
The effect of glia-glia interactions on oligodendrocyte precursor cell biology during development and in demyelinating diseases.
Restless legs syndrome associated with major diseases: A systematic review and new concept.
Steering through complexity: management approaches in multiple sclerosis.
Functional clinical outcomes in multiple sclerosis: Current status and future prospects.
Multiple Sclerosis and the Iranian Revolution: Reply to the Comment by Magzhi et al..
Increased IL-17A but Decreased IL-27 Serum Levels in Patients with Multiple Sclerosis.
Microcystic Inner Nuclear Layer Abnormalities and Neuromyelitis Optica.
Acute transverse myelitis (ascending myelitis) as the initial manifestation of Japanese encephalitis: a rare presentation.
Costs of formal and informal home care and quality of life for patients with multiple sclerosis in sweden.
Enhanced patient support services improve patient persistence with multiple sclerosis treatment.
Low levels of vitamin d in neuromyelitis optica spectrum disorder: association with disease disability.
CLINICAL PROBLEM-SOLVING. A Breakthrough Diagnosis.
Caregiving in Multiple Sclerosis and Quality of Life: A Meta-synthesis of Qualitative Research.
Association study of four polymorphisms in the interleukin-7 receptor alpha gene with multiple sclerosis in Eastern Iran.
Caruifolin D from artemisia absinthium L. inhibits neuroinflammation via reactive oxygen species-dependent c-jun N-terminal kinase and protein kinase c/NF-κB signaling pathways.
Is β-catenin neutralization cross-involved in the mechanisms mediated by natalizumab action?
A prospective observational post-marketing study of natalizumab-treated multiple sclerosis patients: clinical, radiological and biological features and adverse events. The BIONAT cohort.
Pages
« first
‹ previous
…
487
488
489
490
491
492
493
494
495
…
next ›
last »